Barrington Research Maintains Outperform on Option Care Health, Lowers Price Target to $32

Benzinga Newsdesk www.benzinga.com Negative 95.7%

Neg 95.7% Neu 0% Pos 0%

Barrington Research analyst Michael Petusky maintains Option Care Health (NASDAQ:OPCH) with a Outperform and lowers the price target from $42 to $32.